Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
Intervention1: Ginkgo biloba: The oral route of administration in solid form (30 number globules size)of desired potency will be considered as 1 dose given after case taking repetition will be based o
Sponsors
Bakson Medical college & hospital
Eligibility
Inclusion criteria
Inclusion criteria: Clinicaly diagnosed cases of ADHD. Childrens from 3 to 17 years of age of both the sexes male and female. Participants who are taking different types of therapies. Participants willing to give assent or consent by the legal guardians
Exclusion criteria
Exclusion criteria: Participants suffering with severe systemic illness or any immuno-compromised conditions, severe psychiatric illness, substance abuse and endocrine disorders. Participants taking any form of treatment since last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome of the study will be assessed through changes in Conners parent rating scale in ADHD childrens before and after our medicine Timepoint: scale will be assessed at baseline 3 months 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Puneet Garg
Bakson Homoeopathic Medical College & Hospital
Outcome results
None listed